Goldman Sachs Group Inc Inhibrx, Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Inhibrx, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 376,540 shares of INBX stock, worth $5.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
376,540
Previous 153,180 145.82%
Holding current value
$5.34 Million
Previous $5.82 Million 126.17%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$32.76 - $39.56 $7.32 Million - $8.84 Million
223,360 Added 145.82%
376,540 $13.2 Million
Q4 2023

Feb 13, 2024
SELL
$14.5 - $38.0 $91,190 - $238,982
-6,289 Reduced 3.94%
153,180 $5.82 Million
Q3 2023

May 14, 2024
BUY
$15.75 - $26.31 $99,051 - $165,463
6,289 Added 4.11%
159,469 $2.93 Million
Q3 2023

Nov 14, 2023
SELL
$15.75 - $26.31 $1.43 Million - $2.39 Million
-90,948 Reduced 36.32%
159,469 $2.93 Million
Q2 2023

May 14, 2024
BUY
$16.96 - $27.82 $1.28 Million - $2.09 Million
75,236 Added 42.95%
250,417 $6.5 Million
Q2 2023

Aug 14, 2023
BUY
$16.96 - $27.82 $1.28 Million - $2.09 Million
75,236 Added 42.95%
250,417 $6.5 Million
Q1 2023

May 14, 2024
BUY
$18.45 - $27.14 $54,630 - $80,361
2,961 Added 1.72%
175,181 $3.31 Million
Q1 2023

May 11, 2023
BUY
$18.45 - $27.14 $54,630 - $80,361
2,961 Added 1.72%
175,181 $3.31 Million
Q4 2022

May 14, 2024
BUY
$20.18 - $33.33 $341,364 - $563,810
16,916 Added 10.89%
172,220 $4.24 Million
Q4 2022

Feb 13, 2023
BUY
$20.18 - $33.33 $341,364 - $563,810
16,916 Added 10.89%
172,220 $4.24 Million
Q3 2022

May 14, 2024
BUY
$11.58 - $24.73 $866,844 - $1.85 Million
74,857 Added 93.05%
155,304 $2.79 Million
Q3 2022

Nov 10, 2022
BUY
$11.58 - $24.73 $866,844 - $1.85 Million
74,857 Added 93.05%
155,304 $2.79 Million
Q2 2022

May 14, 2024
SELL
$8.52 - $25.26 $619,685 - $1.84 Million
-72,733 Reduced 47.48%
80,447 $914,000
Q2 2022

Aug 15, 2022
SELL
$8.52 - $25.26 $545,552 - $1.62 Million
-64,032 Reduced 44.32%
80,447 $914,000
Q1 2022

May 16, 2022
BUY
$19.89 - $43.18 $445,794 - $967,793
22,413 Added 18.36%
144,479 $3.22 Million
Q4 2021

Feb 14, 2022
SELL
$26.75 - $46.02 $1.14 Million - $1.95 Million
-42,467 Reduced 25.81%
122,066 $5.33 Million
Q3 2021

Nov 10, 2021
BUY
$25.18 - $37.81 $4.14 Million - $6.22 Million
164,533 New
164,533 $5.48 Million

Others Institutions Holding INBX

# of Institutions
132
Shares Held
35.5M
Call Options Held
64.8K
Put Options Held
91.3K
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $553M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email